• Fierce Pharma
  • Fierce Biotech
  • Fierce Healthcare
  • Fierce Life Sciences Events
  • Advertise
  • About Us
Home
  • Pharma
    • Vaccines
    • Asia
    • Cell & Gene Therapy
    • Drug Delivery
    • Executives
  • Manufacturing
    • Facilities
    • Recalls
    • Warning Letters
  • Marketing
  • Special Reports
  • Fierce 50
    • Special Report
    • Awards Gala
  • Trending
    • Oncology
  • Awards
    • CRO Awards
    • Innovation Awards
    • Pharma Marketing Awards
  • Resources
    • Podcasts
    • Fierce Events
    • Industry Events
    • Webinars
    • Whitepapers
    • Survey
  • Events
  • Subscribe
Home
Subscribe
Hamburger Menu Hamburger Menu
  • Pharma
    • Vaccines
    • Asia
    • Cell & Gene Therapy
    • Drug Delivery
    • Executives
  • Manufacturing
    • Facilities
    • Recalls
    • Warning Letters
  • Marketing
  • Special Reports
  • Fierce 50
    • Special Report
    • Awards Gala
  • Trending
    • Oncology
  • Awards
    • CRO Awards
    • Innovation Awards
    • Pharma Marketing Awards
  • Resources
    • Podcasts
    • Fierce Events
    • Industry Events
    • Webinars
    • Whitepapers
    • Survey
  • Events
  • Subscribe
  • Fierce Pharma
  • Fierce Biotech
  • Fierce Healthcare
  • Fierce Life Sciences Events
  • Advertise
  • About Us

Abbott Laboratories

Conspiracy boardinvestigation
Pharma

Amgen is the latest drugmaker in Senate committee's tax probe

Amgen has paid an average effective tax rate of just 12% over the past four years, according to the chair of the U.S. Senate Committee on Finance.
Fraiser Kansteiner Aug 12, 2022 8:56am
Miles White and Robert Ford

Longtime Abbott chief Miles White to step down as CEO

Nov 13, 2019 12:02pm
Bangalore Bengaluru India

Opioid makers eye new market in India as U.S. backlash grows

Aug 30, 2019 8:09am
money

Billions in pharma tax savings went to investors, not R&D: Oxfam

Apr 15, 2019 10:12am
Heather Bresch

Mylan CEO's EpiPen defense reverberates in pricing debate

Jun 4, 2018 11:06am
mylan

Mylan eyes thousands of layoffs in post-M&A revamp

Dec 7, 2016 8:19am

Home
  • Connect
    • The Team
    • Advertise
    • Marketing Kit
    • Let's Talk
  • Join Us
    • Newsletters
    • Resources
    • RSS Feeds
  • Our Brands
    • Fierce Biotech
    • Fierce Healthcare
    • Fierce Pharma
  • Our Events
    • Life Sciences Events
©2025 Questex LLC All rights reserved.
Terms of use
Privacy Policy
Privacy Settings